Cellromax Science Co., Ltd. (KOSDAQ:471820)
South Korea · Delayed Price · Currency is KRW 5,230.00
-10.00 (-0.19%)
At close: Apr 23, 2026
Cellromax Science Market Cap
Cellromax Science has a market cap or net worth of 58.07 billion as of April 24, 2026. Its market cap has increased by 11.20% in one year.
Market Cap
58.07B
Enterprise Value
50.85B
Revenue
22.18B
Ranking
n/a
PE Ratio
20.15
Stock Price
5,230.00
Market Cap Chart
Since December 13, 2024, Cellromax Science's market cap has decreased from 92.69B to 58.07B, a decrease of -37.34%. That is a compound annual growth rate of -29.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2026 | 58.07B | -21.07% |
| Dec 30, 2025 | 73.57B | 28.56% |
| Dec 30, 2024 | 57.23B | -38.25% |
| Dec 13, 2024 | 92.69B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BBIA Co., Ltd. | 85.96B |
| ERCOHS Agricultural Corporation Co.,Ltd | 81.88B |
| GITSN | 77.08B |
| ALT Co., Ltd. | 71.94B |
| Laseroptek | 68.57B |
| Korea No.14 Special Purpose Acquisition | 60.48B |
| JNB Co., Ltd. | 58.95B |
| Catis. | 48.96B |